Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06130345 · ClinicalTrials.gov registry record
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 15,196,685
- Enrollment target
NCT06130345 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 15,196,685 participants.
The verdict
NCT06130345 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 15,196,685 participants
- Enrollment target
Study Summary
The main objective of the study is to evaluate the safety of the elasomeran/davesomeran and andusomeran vaccines as used in routine clinical practice.
Interventions
- BIOLOGICAL SPIKEVAX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,196,685 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06130345
The ClinicalTrials.gov registry entry for NCT06130345 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15,196,685 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SPIKEVAX is the first listed.
NCT06130345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06130345 about?
NCT06130345 is a clinical study titled "Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran". The main objective of the study is to evaluate the safety of the elasomeran/davesomeran and andusomeran vaccines as used in routine clinical practice.
What is the current status of trial NCT06130345?
This trial is currently completed. The enrollment target is 15,196,685 participants. The study started on 2023-04-14. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT06130345?
The interventions under investigation include: SPIKEVAX (BIOLOGICAL).
Who is sponsoring clinical trial NCT06130345?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.